Extracellular succinate, upon binding to succinate receptor-1 (SUCNR-1), activates several oncogenic signaling molecules, such as ERK1/2, Akt, and AMPK, thereby enhancing tumor cell invasion and metastasis (75–77). The gene discussed is SUCNR1; the disease is neoplasm.